{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T01:28:06Z","timestamp":1778203686717,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytica Chimica Acta"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.aca.2021.338593","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T16:45:58Z","timestamp":1619801158000},"page":"338593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["A GLUT1 inhibitor-based fluorogenic probe for Warburg effect-targeted drug screening and diagnostic imaging of hyperglycolytic cancers"],"prefix":"10.1016","volume":"1167","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5407-1424","authenticated-orcid":false,"given":"Shunjie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujun","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9096-5030","authenticated-orcid":false,"given":"Weijie","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4460-2903","authenticated-orcid":false,"given":"Shibo","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingzhi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengnan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.aca.2021.338593_bib1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/annonc\/mds191","article-title":"Imaging of triple-negative breast cancer","volume":"23","author":"Dogan","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.aca.2021.338593_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2020.213318","article-title":"Recent advances in the development of NIR-II organic emitters for biomedicine","volume":"415","author":"Li","year":"2020","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.aca.2021.338593_bib3","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.cclet.2020.11.056","article-title":"Recent advances in the development of activatable multifunctional probes for in\u00a0vivo imaging of caspase-3","volume":"32","author":"Wang","year":"2021","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.aca.2021.338593_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120315","article-title":"NIR-II emissive multifunctional AIEgen with single laser-activated synergistic photodynamic\/photothermal therapy of cancers and pathogens","volume":"259","author":"Xu","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.aca.2021.338593_bib5","doi-asserted-by":"crossref","first-page":"8348","DOI":"10.1039\/C9SC03504D","article-title":"Rational design of a multifunctional molecular dye for dual-modal NIR-II\/photoacoustic imaging and photothermal therapy","volume":"10","author":"Zhang","year":"2019","journal-title":"Chem. Sci."},{"key":"10.1016\/j.aca.2021.338593_bib6","doi-asserted-by":"crossref","first-page":"7023","DOI":"10.1039\/C9SC02466B","article-title":"A\u00a0nano-cocktail of an NIR-II emissive fluorophore and organoplatinum(II) metallacycle for efficient cancer imaging and therapy","volume":"10","author":"Feng","year":"2019","journal-title":"Chem. Sci."},{"key":"10.1016\/j.aca.2021.338593_bib7","doi-asserted-by":"crossref","first-page":"S594","DOI":"10.21037\/tcr.2018.05.22","article-title":"CD73: a new biomarker in triple-negative breast cancer","volume":"7","author":"Lafont","year":"2018","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.aca.2021.338593_bib8","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3892\/ijo.2020.5135","article-title":"Triple-negative breast cancer therapy: current and future perspectives (Review)","volume":"57","author":"Won","year":"2020","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.aca.2021.338593_bib9","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1007\/s00259-015-3110-x","article-title":"Do clinical, histological or immunohistochemical primary tumour characteristics translate into different (18)F-FDG PET\/CT volumetric and heterogeneity features in stage II\/III breast cancer","volume":"42","author":"Groheux","year":"2015","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.aca.2021.338593_bib10","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s00259-016-3402-9","article-title":"18F-FDG-PET\/CT for systemic staging of newly diagnosed triple-negative breast cancer","volume":"43","author":"Ulaner","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.aca.2021.338593_bib11","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s13277-013-0707-1","article-title":"Metabolic phenotypes in triple-negative breast cancer","volume":"34","author":"Kim","year":"2013","journal-title":"Tumor Biol."},{"key":"10.1016\/j.aca.2021.338593_bib12","first-page":"1637","article-title":"The Warburg effect and glucose-derived cancer theranostics, Drug Discov","volume":"22","author":"Tekade","year":"2017","journal-title":"Today Off."},{"key":"10.1016\/j.aca.2021.338593_bib13","first-page":"999","article-title":"Impact of animal handling on the results of 18F-FDG PET studies in mice","volume":"47","author":"Fueger","year":"2006","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.aca.2021.338593_bib14","doi-asserted-by":"crossref","DOI":"10.1117\/1.3259364","article-title":"Evaluation and clinically relevant applications of a fluorescent imaging analog to fluorodeoxyglucose positron emission tomography","volume":"14","author":"Sheth","year":"2009","journal-title":"J.\u00a0Biomed. Opt."},{"key":"10.1016\/j.aca.2021.338593_bib15","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1002\/ijc.24222","article-title":"Molecular imaging of glucose uptake in oral neoplasia following topical application of fluorescently labeled deoxy-glucose","volume":"124","author":"Nitin","year":"2009","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.aca.2021.338593_bib16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/chem.201002560","article-title":"Development of fluorescent glucose bioprobes and their application on real-time and quantitative monitoring of glucose uptake in living cells, Chem","volume":"17","author":"Lee","year":"2011","journal-title":"Eur. J."},{"key":"10.1016\/j.aca.2021.338593_bib17","doi-asserted-by":"crossref","first-page":"12.14.1","DOI":"10.1002\/0471141755.ph1214s71","article-title":"Measurement of glucose uptake in cultured cells","volume":"71","author":"Yamamoto","year":"2015","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.aca.2021.338593_bib18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/cas.12085","article-title":"Cancer metabolism: key players in metabolic reprogramming","volume":"104","author":"Soga","year":"2013","journal-title":"Canc. Sci."},{"key":"10.1016\/j.aca.2021.338593_bib19","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1172\/JCI67228","article-title":"Linking altered metabolism with cancer","volume":"123","author":"Yang","year":"2013","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.aca.2021.338593_bib20","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nature11706","article-title":"How cancer metabolism is tuned for proliferation and vulnerable to disruption","volume":"491","author":"Schulze","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.aca.2021.338593_bib21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrc2981","article-title":"Regulation of cancer cell metabolism","volume":"11","author":"Cairns","year":"2011","journal-title":"Nat. Rev."},{"key":"10.1016\/j.aca.2021.338593_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/cbic.201900544","article-title":"Small-molecule inhibition of glucose transporters GLUT-1-4","volume":"21","author":"Reckzeh","year":"2020","journal-title":"ChemBioChem"},{"key":"10.1016\/j.aca.2021.338593_bib23","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/cmdc.201600276","article-title":"Identification and optimization of the first highly selective GLUT1 inhibitor BAY-876","volume":"11","author":"Siebeneicher","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.aca.2021.338593_bib24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/cancers11010033","article-title":"Ovarian cancer relies on glucose transporter 1 to fuel glycolysis and growth: anti-tumor activity of BAY-876","volume":"11","author":"Ma","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.aca.2021.338593_bib25","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.bmcl.2010.02.027","article-title":"Novel inhibitors of basal glucose transport as potential anticancer agents","volume":"20","author":"Zhang","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.aca.2021.338593_bib26","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1158\/1535-7163.MCT-12-0131","article-title":"A\u00a0small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in\u00a0vitro and in\u00a0vivo","volume":"11","author":"Liu","year":"2012","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.aca.2021.338593_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002394","article-title":"Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality","volume":"3","author":"Chan","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.aca.2021.338593_bib28","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s13402-018-0385-5","article-title":"Targeting glucose transport and the NAD pathway in tumor cells with STF-31: a re-evaluation","volume":"41","author":"Kraus","year":"2018","journal-title":"Cell Oncol. (Dordr)"},{"key":"10.1016\/j.aca.2021.338593_bib29","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.1016\/S0021-9258(19)63372-7","article-title":"Cytochalasin B binding sites and glucose transport carrier in human erythrocyte ghosts","volume":"252","author":"Jung","year":"1977","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.aca.2021.338593_bib30","series-title":"Glucose Transport Inhibitors","author":"Heisler","year":"2013"},{"key":"10.1016\/j.aca.2021.338593_bib31","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.bmcl.2016.02.050","article-title":"Identification of novel GLUT inhibitors, Bioorg","volume":"26","author":"Siebeneicher","year":"2016","journal-title":"Med. Chem. Lett."},{"key":"10.1016\/j.aca.2021.338593_bib32","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1073\/pnas.1603735113","article-title":"Mechanism of inhibition of human glucose transporter GLUT1 is conserved between cytochalasin B and phenylalanine amides","volume":"113","author":"Kapoor","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.aca.2021.338593_bib33","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/jcp.17.4.371","article-title":"Fluorescence of solutions: a review","volume":"17","author":"Williams","year":"1964","journal-title":"J.\u00a0Clin. Pathol."},{"key":"10.1016\/j.aca.2021.338593_bib34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jbbm.2005.08.001","article-title":"2-NBDG as a fluorescent indicator for direct glucose uptake measurement","volume":"64","author":"Zou","year":"2005","journal-title":"J.\u00a0Biochem. Biophys. Methods"},{"key":"10.1016\/j.aca.2021.338593_bib35","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.1016\/S0021-9258(18)45595-0","article-title":"Equilibrium ligand binding to the human erythrocyte sugar transporter. Evidence for two sugar-binding sites per carrier","volume":"262","author":"Helgerson","year":"1987","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.aca.2021.338593_bib36","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1042\/bj2490383","article-title":"Inhibition by nucleosides of glucose-transport activity in human erythrocytes","volume":"249","author":"Jarvis","year":"1988","journal-title":"Biochem. J."},{"key":"10.1016\/j.aca.2021.338593_bib37","doi-asserted-by":"crossref","first-page":"8075","DOI":"10.1021\/bi0256328","article-title":"Nicotinamide is not a substrate of the facilitative hexose transporter GLUT1","volume":"41","author":"Reyes","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.aca.2021.338593_bib38","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cbi.2003.06.001","article-title":"The inhibitory effects of flavonoids and antiestrogens on the Glut1 glucose transporter in human erythrocytes","volume":"146","author":"Martin","year":"2003","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.aca.2021.338593_bib39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.biochi.2018.05.012","article-title":"Quercetin inhibits glucose transport by binding to an exofacial site on GLUT1","volume":"151","author":"Hamilton","year":"2018","journal-title":"Biochimie"},{"key":"10.1016\/j.aca.2021.338593_bib40","doi-asserted-by":"crossref","first-page":"8834","DOI":"10.1021\/bi200748b","article-title":"Hexose transporter GLUT1 harbors several distinct regulatory binding sites for flavones and tyrphostins","volume":"50","author":"Perez","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.aca.2021.338593_bib41","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1021\/bi00230a015","article-title":"Inhibitions of sugar transport produced by ligands binding at opposite sides of the membrane. Evidence for simultaneous occupation of the carrier by maltose and cytochalasin B","volume":"30","author":"Carruthers","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.aca.2021.338593_bib42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.biochi.2013.12.003","article-title":"Alkaline pH activates the transport activity of GLUT1 in L929 fibroblast cells","volume":"99","author":"Gunnink","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.aca.2021.338593_bib43","doi-asserted-by":"crossref","first-page":"99e","DOI":"10.1016\/j.biochi.2017.03.011","article-title":"Caffeine inhibition of GLUT1 is dependent on the activation state of the transporter","volume":"137","author":"Gunnink","year":"2017","journal-title":"Biochimie"},{"key":"10.1016\/j.aca.2021.338593_bib44","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0014-4827(61)90033-7","article-title":"The effect of rotenone on respiration and its point of attack","volume":"23","author":"Lindahl","year":"1961","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.aca.2021.338593_bib45","first-page":"F133","article-title":"Metabolic inhibitors: effects on metabolism and transport in the proximal tubule","volume":"243","author":"Gullans","year":"1982","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.aca.2021.338593_bib46","first-page":"999","article-title":"Impact of animal handling on the results of 18F-FDG PET studies in mice","volume":"47","author":"Fueger","year":"2006","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.aca.2021.338593_bib47","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1007\/s12035-015-9672-6","article-title":"Glucose transporters at the blood-brain barrier: function, regulation and gateways for drug delivery","volume":"54","author":"Patching","year":"2017","journal-title":"Mol. Neurobiol."}],"container-title":["Analytica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003267021004190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003267021004190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:32:23Z","timestamp":1757705543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003267021004190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":47,"alternative-id":["S0003267021004190"],"URL":"https:\/\/doi.org\/10.1016\/j.aca.2021.338593","relation":{},"ISSN":["0003-2670"],"issn-type":[{"value":"0003-2670","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A GLUT1 inhibitor-based fluorogenic probe for Warburg effect-targeted drug screening and diagnostic imaging of hyperglycolytic cancers","name":"articletitle","label":"Article Title"},{"value":"Analytica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aca.2021.338593","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"338593"}}